A validated method for the determination of hematocrit in dried blood spots using image analysis
Abstract
Aim: To develop a nondestructive method for the estimation of hematocrit (HCT) in dried blood spots (DBSs). Materials & methods: Standards and controls were created (HCT range: 0.20–0.50 l/l) and DBS scanned using a flatbed scanner. Gray values and pixel areas were analyzed with open-source software to estimate HCT and volume, respectively. HCT obtained in whole blood using hematological analyzer was compared with DBS scanner method (n = 50). Results: Between-run precision was 4.7–10.2% and between-run accuracy was 89.6–102.1%. In the hematological instrument comparison, 96% of the patient sample results were within ±15%. Conclusion: The nondestructive method can be used to exclude patient DBS samples with extreme HCT levels from further analysis and avoid bias on measured concentration.
Graphical abstract
Papers of special note have been highlighted as: • of interest; •• of considerable interest
References
- 1. . State of the science in dried blood spots. Clin. Chem. 64(4), 656–679 (2018). • Thorough review of published dried blood spot methods and analytes.
- 2. . Self-sampling and quantitative analysis of DBS: can it shift the balance in over-burdened healthcare systems? Bioanalysis 7(16), 1963–1966 (2015).
- 3. Parents' perspectives on dried blood spot self-sampling from children with epilepsy: a mixed-method study. Acta Paediatr. Int. J. Paediatr. 409(12), 1–10 (2020).
- 4. . Microsampling devices for routine therapeutic drug monitoring – are we there yet? Ther. Drug Monit. 43(3), 322–334 (2021).
- 5. . Hematocritical issues in quantitative analysis of dried blood spots: challenges and solutions. Bioanalysis 5(16), 2023–2041 (2013).
- 6. . Is the hematocrit still an issue in quantitative dried blood spot analysis? J. Pharm. Biomed. Anal. 163, 188–196 (2019). • This review covers how to tackle hematocrit issues.
- 7. . Evaluation of factors influencing precision in the analysis of samples taken from blood spots on filter paper. Clin. Lab. Haematol. 17(2), 185–188 (1995). • Describes variation of blood cells and plasma volumes within dried blood spot punches.
- 8. . The effect of hematocrit on assay bias when using DBS samples for the quantitative bioanalysis of drugs. Bioanalysis 2(8), 1385–1395 (2010). • An introduction and explanation of the hematocrit problem with dried blood spots.
- 9. . The effect of hematocrit and punch location on assay bias during quantitative bioanalysis of dried blood spot samples. Bioanalysis 3(20), 2335–2347 (2011).
- 10. Implementing dried blood spot sampling for clinical pharmacokinetic determinations: considerations from the IQ Consortium Microsampling Working Group. AAPS J. 17(2), 292–300 (2015).
- 11. . Solutions for hematocrit bias in dried blood spot hormone analysis. Bioanalysis 13(16), 1293–1308 (2021). • A review that covers the latest advantages of and methods used to tackle the problem of hematocrit bias.
- 12. . Prediction of the hematocrit of dried blood spots via potassium measurement on a routine clinical chemistry analyzer. Anal. Chem. 85(1), 404–410 (2013).
- 13. . Potassium-based algorithm allows correction for the hematocrit bias in quantitative analysis of caffeine and its major metabolite in dried blood spots. Anal. Bioanal. Chem. 406, 6749–6755 (2014).
- 14. . An on-card approach for assessment of hematocrit on dried blood spots which allows for correction of sample volume. J. Anal. Bioanal. Tech. 4(1), 1–8 (2013).
- 15. . Prediction of haematocrit in dried blood spots from the measurement of haemoglobin using commercially available sodium lauryl sulphate. Ann. Clin. Biochem. 55(3), 363–367 (2018).
- 16. . A novel, nondestructive, dried blood spot-based hematocrit prediction method using noncontact diffuse reflectance spectroscopy. Anal. Chem. 88(12), 6538–6546 (2016).
- 17. . Correction for the hematocrit bias in dried blood spot analysis using a nondestructive, single-wavelength reflectance-based hematocrit prediction method. Anal. Chem. 90, 1795–1804 (2018).
- 18. . Measurement of hematocrit in dried blood spots using near infrared spectroscopy: robust, fast and nondestructive. Clin. Chem. 62(11), 1533–1534 (2016).
- 19. Development and validation of hematocrit level measurement in dried blood spots using near-infrared spectroscopy. Ther. Drug Monit. 43(3), 351–357 (2021).
- 20. . Volumetric absorptive microsampling: a dried sample collection technique for quantitative bioanalysis. Anal. Chem. 86, 8489–8495 (2014).
- 21. . Volumetric absorptive microsampling: current advances and applications. J. Pharm. Biomed. Anal. 147, 288–296 (2018).
- 22. . A disposable sampling device to collect volume-measured DBS directly from a fingerprick onto DBS paper. Bioanalysis 7(16), 2085–2094 (2015).
- 23. New microfluidic-based sampling procedure for overcoming the hematocrit problem associated with dried blood spot analysis. Anal. Chem. 87(4), 2068–2071 (2015).
- 24. . A new DBS card with spot sizes independent of the hematocrit value of blood. Bioanalysis 7(16), 2095–2104 (2015).
- 25. . Development of a hematocrit-insensitive device to collect accurate volumes of dried blood spots without specialized skills for measuring clozapine and its metabolites as model analytes. J. Chromatogr. B 1087–1088, 70–79 (2018).
- 26. . Letter to the editor. A fast, nondestructive, low-cost method for the determination of hematocrit of dried blood spots using image analysis. Clin. Chem. Lab. Med. 57(5), 81–82 (2019). •• Letter to the editor that introduces the possibility of using an imaging technique as a way of estimating hematocrit.
- 27. What is the right blood hematocrit preparation procedure for standards and quality control samples for dried blood spot analysis? Bioanalysis 7(3), 345–351 (2015).
- 28. . Use of filter paper for the collection and analysis of human whole blood specimens. J. Nutr. 131, 1631–1636 (2001).
- 29. . Determination of moxifloxacin in dried blood spots using LC–MS/MS and the impact of the hematocrit and blood volume. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 879(15–16), 1063–1070 (2011).
- 30. . A LC–MS/MS method for therapeutic drug monitoring of carbamazepine, lamotrigine and valproic acid in DBS. Bioanalysis 7(16), 2031–2039 (2015).
- 31. . The effect of drying on the homogeneity of DBS. Bioanalysis 7(16), 1977–1985 (2015).
- 32. . Carbamazepine, lamotrigine, levetiracetam and valproic acid in dried blood spots with liquid chromatography tandem mass spectrometry; method development and validation. J. Chromatogr. B 1072, 116–122 (2018).
- 33. . Health promotion glossary. Health Promot. Int. 13(4), 349–364 (1998).
- 34. . Patient empowerment in the United States: a critical commentary. Heal. Expect. 2(2), 82–92 (1999).
- 35. . Alternative sampling devices to collect dried blood microsamples: state-of-the-art. Ther. Drug Monit. 43(3), 310–321 (2021).